Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT01216332
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients with standard or high risk Acute Lymphoblastic Leukemia.
* Must be in 1st complete remission.
* Must be 4 weeks into maintenance therapy.
* 17 years of age, inclusive.
* Available for duration of study.
Exclusion Criteria:
* History of hypersensitivity to previous influenza vaccination or hypersensitivity to eggs/egg protein.
* History of Guillain-Barre syndrome.
* Evidence of relapsed disease.
* Have any condition that would, in the opinion of the site investigator, place them at an unacceptable risk of injury or render them unable to meet the requirements of the protocol.
* Have any condition that the investigator believes may interfere with successful completion of the study.
* History of receiving 2010 - 2011 influenza vaccine.
* Pregnant female.
* History of proven influenza disease after September 1, 2010.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
17 Years
Study:
NCT01216332
Study Brief:
Protocol Section:
NCT01216332